top of page
Old Study

LITERATURE REFERENCES

Literature References

 Ketamine for Trauma PTSD

Albott CS et al. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. J Clin Psychiatry. 2018 May/Jun;79(3).

Feder A et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder, A Randomized Clinical Trial. JAMA Psychiatry. 2014;71(6):681–688.

Selected References Off-Label Use of Ketamine for Depression

 

  • Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020 May 11;10:2045125320916657. doi: 10.1177/2045125320916657. PMID: 32440333; PMCID: PMC7225830.

​​​​​​​

  • Grady SE, Marsh TA, Tenhouse A, Klein K. Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature. Ment Health Clin. 2017 Jan;7(1) 16-23.

  • Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci, 11(9), 642-651.

  • Serafini, G. et al. NMDA receptor antagonists for depression: Critical considerations. Ann Clin Psychiatry (2015), 27(3), 213-220.

  • Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol. 2014;12(5):444-61.

  • Murrough, J. et al. Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial. Psychological Medicine (2015), 45(16), 3571-3580.

bottom of page